Kestine Smelt 20

Ebastine, the active ingredient in Kestine Smelt 20, is a second‑generation antihistamine presented as a 20 mg tablet for oral use. It works by selectively blocking peripheral H1‑receptors, reducing histamine‑mediated allergic symptoms, and is indicated for the relief of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents.

GNH USA supplies Kestine Smelt 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Ebastine, a second‑generation antihistamine, blocks peripheral H1‑receptors to alleviate allergic conditions.

- Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge. - Chronic idiopathic urticaria: decreases frequency and severity of hives and itching. - Seasonal allergic rhinitis: provides symptom control during pollen exposure.

Ebastine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity. - Dry mouth: transient sensation of oral dryness. - Drowsiness: occasional mild sedation. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes or hepatitis.

When using Kestine Smelt 20, consider the following precautions.

- Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: avoid unless physician advises; ebastine may pass into milk. - Renal impairment: dose adjustment may be required in severe cases. - Elderly patients: monitor for increased sedation or dizziness. - Drug interactions: avoid concomitant strong CYP3A4 inhibitors. - Store at ambient temperature: keep below 25 °C, retain in original packaging and protect from moisture.

Potential drug interactions with ebastine should be reviewed before therapy.

Major Interactions (Avoid): - Ketoconazole: potent CYP3A4 inhibitor that can raise ebastine plasma levels. - Erythromycin: macrolide antibiotic that may increase ebastine exposure. - Ritonavir: strong CYP3A4 inhibitor leading to elevated ebastine concentrations.

Moderate Interactions (Monitor Closely): - Theophylline: may reduce antihistaminic effect of ebastine. - Antihypertensive agents: additive sedative effects may occur. - Alcohol: can enhance drowsiness.